Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LETAIRIS
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
- Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- The Role of Endothelin-1 in Sickle Cell Disease
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
- Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude
- The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers
- Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529
- An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)
- Efficacy and Safety of Ambrisentan in Children 8-18yrs
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
- Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
- Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
- Study of Ambrisentan in Participants With Pulmonary Hypertension
- A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
Clinical trials list
click for details